National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 104196-104197 [2024-30360]
Download as PDF
<![CDATA[
ddrumheller on DSK120RN23PROD with NOTICES1
104196
Federal Register / Vol. 89, No. 245 / Friday, December 20, 2024 / Notices
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–8: NCI
Clinical and Translational Cancer Research.
Date: February 25, 2025.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Cancer Institute at
Shady Grove 9609 Medical Center Drive,
Room 7W110, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Priya Srinivasan, Ph.D.,
Scientific Review Officer, Resource and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W110, Rockville, Maryland 20850,
240–276–5619, priya.srinivasan@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; TEP–1:
SBIR Contract Review Meeting.
Date: February 26, 2025.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract
proposals.
Address: National Cancer Institute at
Shady Grove 9609 Medical Center Drive,
Room 7W624, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Ombretta Salvucci, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W264, Rockville,
Maryland 20850, 240–276–7286, salvucco@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; TEP–3:
SBIR Contract Review.
Date: February 27, 2025.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract
proposals.
Address: National Cancer Institute at
Shady Grove, 9609 Medical Center Drive,
Room 7W106, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Eduardo Emilio Chufan,
Ph.D., Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W106, Rockville, Maryland
20850, 240–276–7975, chufanee@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–6: NCI
Clinical and Translational Cancer Research.
Date: February 28, 2025.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Cancer Institute at
Shady Grove, 9609 Medical Center Drive,
Room 7W260, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Robert F. Gahl, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9606 Medical
Center Drive, Room 7W260, Rockville,
Maryland 20850, 240–276–7869, robert.gahl@
nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–1: NCI
Clinical and Translational Cancer Research.
VerDate Sep<11>2014
20:12 Dec 19, 2024
Jkt 265001
Date: March 6, 2025.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Cancer Institute at
Shady Grove, 9609 Medical Center Drive,
Room 7W108, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Clifford W. Schweinfest,
Ph.D., Scientific Review Officer, Special
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W108,
Rockville, Maryland 20850, 240–276–6343,
schweinfestcw@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Cancer
Prevention and Control Clinical Trials
Planning.
Date: March 6, 2025.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Cancer Institute at
Shady Grove, 9609 Medical Center Drive,
Room 7W608, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Nadeem Khan, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W608, Rockville, Maryland
20850, 240–276–5856, nadeem.khan@
nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; TEP–9:
SBIR Contract Review Meeting.
Date: March 7, 2025.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate contract
proposals.
Address: National Cancer Institute at
Shady Grove, 9609 Medical Center Drive,
Room 7W612, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Prashant Sharma, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W612, Rockville,
Maryland 20850, 240–275–6351,
prashant.sharma@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–13:
NCI Clinical and Translational Cancer
Research.
Date: March 13, 2025.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Cancer Institute at
Shady Grove, 9609 Medical Center Drive,
Room 7W618, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: E. Tian, Ph.D., Scientific
Review Officer, Research Program Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W618, Rockville,
Maryland 20850, 240–276–6611, tiane@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; TEP–10:
SBIR Contract Review Meeting.
PO 00000
Frm 00125
Fmt 4703
Sfmt 4703
Date: March 14, 2025.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate contract
proposals.
Address: National Cancer Institute at
Shady Grove, 9609 Medical Center Drive,
Room 7W238, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Byeong-Chel Lee, Ph.D.,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W238, Rockville, Maryland 20850,
240–276–7755, byeong-chel.lee@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Metastasis
Research Network (U01).
Date: March 21, 2025.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Cancer Institute at
Shady Grove, 9609 Medical Center Drive,
Room 7W120, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Majed M. Hamawy, Ph.D.,
Scientific Review Officer, Research Programs
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive Room 7W120,
Rockville, Maryland 20850, 240–276–6457,
mh101v@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: December 16, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–30326 Filed 12–19–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
E:\FR\FM\20DEN1.SGM
20DEN1
Federal Register / Vol. 89, No. 245 / Friday, December 20, 2024 / Notices
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Dated: December 16, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
Dated: December 16, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; HHS–NIH–CDC–SBIR PHS
2025–1 Phase I and Phase II: Reagents for
Immunologic Analysis of Non-mammalian
and Underrepresented Mammalian Models
(Topic 141).
Date: January 14–16, 2025.
Time: 10:30 a.m. to 1:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G56,
Rockville, MD 20892 (Video Assisted
Meeting).
Contact Person: Poonam Tewary, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G56, Rockville, MD
20892, (301) 761–7219, tewaryp@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
[FR Doc. 2024–30327 Filed 12–19–24; 8:45 am]
[FR Doc. 2024–30363 Filed 12–19–24; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
Center For Scientific Review; Notice of
Closed Meetings
National Center for Advancing
Translational Sciences; Notice of
Closed Meetings
Dated: December 16, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–30360 Filed 12–19–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
ddrumheller on DSK120RN23PROD with NOTICES1
104197
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Special Emphasis Panel,
Informatics Technologies for Cancer
Research, January 29, 2025, 10 a.m. to
January 29, 2025, 6 p.m., National
Cancer Institute Shady Grove, 9609
Medical Center Drive, Room 7W106,
Rockville, Maryland, 20850 which was
published in the Federal Register on
November 27, 2024, FR Doc 2024–
27877, 89 FR 93623.
This notice is being amended to
change the meeting date and time from
January 29, 2025, 10 a.m. to 6 p.m. to
February 6, 2025, 10 a.m. to 6 p.m. and
February 7, 2025, 10 a.m. to 2 p.m. The
meeting format and location will stay
the same. The meeting is closed to the
public.
VerDate Sep<11>2014
20:12 Dec 19, 2024
Jkt 265001
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Drug
Development.
Date: January 7, 2025.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Maureen Shuh, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 480–4097, maureen.shuh@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Topics in
Immunology and Infectious Diseases.
Date: January 14, 2025.
Time: 12 p.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Anthony David Foster,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 496–3297, anthony.foster@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
PO 00000
Frm 00126
Fmt 4703
Sfmt 4703
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; Topic 025: Benchtop Device
to Perform Batch Evaporation.
Date: January 27, 2025.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Address: National Center for Advancing
Translational Sciences, National Institutes of
Health, 9609 Medical Center Drive,
Rockville, MD 20892 (Virtual).
Contact Person: Rahat (Rani) Khan, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Center for Advancing
Translational Sciences, National Institutes of
Health, 9609 Medical Center Drive, Suite
1E504, Rockville, MD 20892, (301) 594–7319,
rahat.khan@nih.gov.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; Topic 026: Liver and Brain
Organoids Derived from Human iPS Cells.
Date: January 29, 2025.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Address: National Center for Advancing
Translational Sciences, National Institutes of
Health, 9609 Medical Center Drive,
Rockville, MD 20892 (Virtual).
Contact Person: Rahat (Rani) Khan, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Center for Advancing
Translational Sciences, National Institutes of
Health, 9609 Medical Center Drive, Suite
1E504, Rockville, MD 20892, (301) 594–7319,
rahat.khan@nih.gov.
E:\FR\FM\20DEN1.SGM
20DEN1
]]>Agencies
[Federal Register Volume 89, Number 245 (Friday, December 20, 2024)]
[Notices]
[Pages 104196-104197]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-30360]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning
[[Page 104197]]
individuals associated with the contract proposals, the disclosure of
which would constitute a clearly unwarranted invasion of personal
privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; HHS-NIH-CDC-SBIR PHS 2025-1 Phase I
and Phase II: Reagents for Immunologic Analysis of Non-mammalian and
Underrepresented Mammalian Models (Topic 141).
Date: January 14-16, 2025.
Time: 10:30 a.m. to 1:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3G56,
Rockville, MD 20892 (Video Assisted Meeting).
Contact Person: Poonam Tewary, Ph.D., Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities,
National Institute of Allergy and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane, Room 3G56, Rockville, MD
20892, (301) 761-7219, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: December 16, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-30360 Filed 12-19-24; 8:45 am]
BILLING CODE 4140-01-P
